A Plain Language Summary of Results from the TORCHLIGHT Trial of Toripalimab Plus Chemotherapy for Metastatic or Recurrent Triple-Negative Breast Cancer Zefei Jiang , Quchang Ouyang , Tao Sun , Qingyuan Zhang , Yuee Teng , Jiuwei Cui , Haibo Wang , Yongmei Yin , Xiaojia Wang , Xin Zhou , Yongsheng Wang , Gang Sun , Jingfen Wang , Lili Zhang , Jin Yang , Jun Qian , Min Yan , Xinlan Liu , Tienan Yi , Ying Cheng , Man Li , Aimin Zang , Shusen Wang , Chuan Wang , Xinhong Wu , Jing Cheng , Hui Li , Ying Lin , Cuizhi Geng , Kangsheng Gu , Chunwei Xie , Huihua Xiong , Xiaohong Wu , Junlan Yang , Qingshan Li , Yiding Chen , Fanfan Li , Anqin Zhang , Yongqiang Zhang , Yudong Wu , Jianyun Nie , Qiang Liu , Kun Wang , Xueli Mo , Lilin Chen , Yueyin Pan , Peifen Fu , Helong Zhang , Danmei Pang , Yuan Sheng , Yunwei Han , Hongxia Wang , Shundong Cang , Xianming Luo , Wenbo Yu , Rong Deng , Chaoqiang Yang , Patricia Keegan Future oncology (London, England)（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
